These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9381611)

  • 1. [Urinary urease activity in urolithiasis patients].
    Merkusheva NV; Iushina LV; Makhonina IA
    Urol Nefrol (Mosk); 1997; (4):13-5. PubMed ID: 9381611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Laboratory methods of predicting primary and recurrent nephrolithiasis].
    Alchinbaev MK; Malik AM; Merkusheva NV; Makhonina IA
    Urologiia; 2000; (5):9-10. PubMed ID: 11392229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urease. The primary cause of infection-induced urinary stones.
    Griffith DP; Musher DM; Itin C
    Invest Urol; 1976 Mar; 13(5):346-50. PubMed ID: 815197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of mucopolysaccharide elimination in urolithiasis].
    Hesse A; Hartmann U; Schneider HJ; Horn G
    Z Urol Nephrol; 1975 Jun; 70(6):401-5. PubMed ID: 127480
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of biochemical methods in follow-up and treatment of patients with urolithiasis].
    Dzeranov NK; Konstantinova OV; Beshliev DA; Golovanov SA; Drozhzheva VV
    Urologiia; 2001; (1):18-20. PubMed ID: 11233224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R; Czkwianianc E; Niedworok M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of recurrence in urolithiasis].
    Terhorst B; Melchior H
    Z Urol Nephrol; 1969; 62(10):761-73. PubMed ID: 4326184
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of the salting-out effect on the formation of calcium oxalate crystals in human urine].
    Kallistratos G; Timmermann A; Fenner O
    Naturwissenschaften; 1970 Apr; 57(4):198. PubMed ID: 5446710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genesis of urolithiasis].
    Schmucki O; Asper R
    Ther Umsch; 1980 May; 37(5):336-41. PubMed ID: 7394754
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease and relationship to urolithiasis.
    Farmer RG; Mir-Madjlessi SH; Kiser WS
    Gut; 1973 Oct; 14(10):828. PubMed ID: 4758698
    [No Abstract]   [Full Text] [Related]  

  • 14. [Guidelines for prevention of recurrent urolithiasis (author's transl)].
    Zechner O
    Wien Klin Wochenschr; 1981 Oct; 93(20):619-24. PubMed ID: 7324473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urolithiasis in adults. Clinical and biochemical aspects.
    Abdel-Halim RE
    Saudi Med J; 2005 May; 26(5):705-13. PubMed ID: 15951854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for uric acid in an animal model of calcium phosphate nephrocalcinosis and calcium phosphate crystallization in urine of patients with idiopathic calcium urolithiasis? An orientational study.
    Schwille PO; Schmiedl A; Manoharan M; Wipplinger J
    J Endourol; 1999 Nov; 13(9):637-45. PubMed ID: 10608515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
    Liu J; Chen J; Wang T; Wang S; Ye Z
    J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Wawrzyszuk M; Zajaczkowska M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():76-9. PubMed ID: 18924510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.